Evaluation of an intensive education program on the treatment of tobacco-use disorder for pharmacists: a study protocol for a randomized controlled trial
DiscussionIf demonstrated to be effective, this education program will be considered as a model that Qatar and the Middle East region can apply to overcome the burden of tobacco-use disorder.Trial registrationClinicalTrials.gov, ID:NCT03518476. Registered on 8 May 2018. Version 1/22 June 2018. (Source: Trials)
Source: Trials - January 8, 2019 Category: Research Source Type: clinical trials

Qatar Cardiovascular Biorepository of AF Patients
Condition:   Atrial Fibrillation Intervention:   Sponsor:   Hamad Medical Corporation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 6, 2018 Category: Research Source Type: clinical trials